The second annual European Symposium on Protein Fractionation and Biomarker Discovery featured papers on a wide range of advances in proteome research
Liquid phase fractionation of the protein sample was shown to provide a powerful tool for biomarker discovery, evaluation of disease processes and development of treatment strategies.
Hosted by Beckman Coulter at Oriel College, Oxford, the two-day meeting attracted over 50 researchers from around the world.
Several speakers highlighted the liquid fractionation method as a complementary technique giving valuable additional information when used in combination with conventional 2D gel studies, revealing protein species not found in the 2D gel analysis.
Beckman Coulter's ProteomeLab PF 2D provides an automated two-dimensional fractionation system, uniquely combining chromatofocusing followed by non-porous reverse phase chromatography for ultra-high resolution of proteins.
A number of PF 2D systems have been placed with the Johns Hopkins NHLBI Proteomic Centre, as part of their synergistic multiple technology platform used to expand the proteome depth.
Presentations also included results obtained from Beckman Coulter's new ProteomeLab IgY system.
This utilises avian antibodies to partition the more abundant proteins from human biofluids, such as plasma and serum, to yield an enrichment of low abundance proteins for subsequent separation by liquid phase fractionation or 2D gel.
Beckman Coulter's ProteomeLab provides a comprehensive set of interrelated solutions designed specifically to accelerate proteomics research.
These encompass virtually every aspect of the proteomics process, including cellular isolation, antigen identification, protein fractionation, protein characterisation, data evaluation and disease diagnosis.
Beckman Coulter is a manufacturer of biomedical testing instrument systems, tests and supplies that simplify and automate laboratory processes.
